Prevalence of thyroid dysfunction in older Chinese patients with type 2 diabetes—A multicenter cross-sectional observational study across China

• DOI: 10.1371/journal.pone.0216151
• Publication Date: 2019-05-02T17:49:46Z
• Authors: Yu Zhu; Fengmei Xu; Jie Shen; Youshuo Liu; Changhua Bi; Jing Liu; Yufeng Li; Xueqin Wang; Zhengnan Gao; Linlang Liang; Yanyan Chen; Weiping Sun; Qingbo Guan; Junqing Zhang; Zuojie Luo; Lixin Guo; Xiaopin Cai; Ling Li; Lingling Xiu; Li Yan; Chunlin Li; Xiaoyun Shi; Mei Zhu; Jian Kuang; Guangwei Li; Linong Ji
• Keywords: Male; China; Science; Q; R; Thyroid Gland; Middle Aged; Hyperthyroidism; Thyroid Diseases; 3. Good health; 03 medical and health sciences; Cross-Sectional Studies; 0302 clinical medicine; Asian People; Diabetes Mellitus, Type 2; Hypothyroidism; Surveys and Questionnaires; Prevalence; Medicine; Humans; Female; Research Article; Aged

Type 2 diabetes [T2D] and thyroid dysfunction [TD] often co-occur, have overlapping pathologies, and their risk increases with age. Since 1995, universal salt iodization has been implemented in China to prevent disorders caused by iodine deficiency. However, after two decades of implementation of universal salt iodization, the prevalence of TD in elderly Chinese patients with T2D is not well described and may have been underestimated. We conducted a questionnaire-based survey across 24 endocrinology centers in China between December 2015 and July 2016. Demographic and clinical data from 1677 patients with T2D were obtained and analyzed to examine the prevalence of TD along with T2D in these patients. We assessed TD prevalence according to the four TD subtypes [subclinical hypothyroidism, clinical hypothyroidism, subclinical hyperthyroidism, and clinical hyperthyroidism], TD history, gender, and age. The diagnosis rates were calculated for TD and also for the TD subtype. The number of patients reaching treatment goals for T2D [hemoglobin A1c <7%] and TD [normal free thyroxine and thyroid-stimulating hormone [TSH]] and the incidences of complications and comorbidities were recorded. Among the enrolled patients with T2D [N = 1677], TD was diagnosed in 23.79% [399/1677] out of which 61% (245/399) were previously diagnosed and 38.59% (154/399) were newly diagnosed cases. Subclinical hypothyroidism, clinical hypothyroidism, subclinical hyperthyroidism, and clinical hyperthyroidism were reported in 4.89%, 9.3%, 1.13%, and 3.16% of the total population, respectively. Among patients previously diagnosed with TD, the incidence in women [166/795; 20.88%] was higher than in men [79/882; 8.96%]. The treatment goals for TD and T2D were attained in 39.6% [97/245] and 34.41% [577/1677] of the cases, respectively. Diabetic complications and comorbidities were reported in 99.7% of patients, with peripheral neuropathy being the most common [43.46%] followed by cataract [24.73%]. We had found that the incidences of dyslipidemia, elevated LDL levels, and osteoporosis were significantly higher in patients with TD than those without TD. TD is underdiagnosed in elderly Chinese patients with T2D.